FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013750047> ?p ?o ?g. }

• W2013750047 endingPage "4167" @default.
• W2013750047 startingPage "4162" @default.
• W2013750047 abstract "Deregulated tyrosine kinase signaling alters cellular homeostasis to drive cancer progression. The emergence of a non-receptor tyrosine kinase (non-RTK), ACK1 (also known as activated Cdc42-associated kinase 1 or TNK2) as an oncogenic kinase, has uncovered novel mechanisms by which tyrosine kinase signaling promotes cancer progression. Although early studies focused on ACK1 as a cytosolic effector of activated transmembrane RTKs, wherein it shuttles between the cytosol and the nucleus to rapidly transduce extracellular signals from the RTKs to the intracellular effectors, recent data unfold a new aspect of its functionality as an epigenetic regulator. ACK1 interacts with the estrogen receptor (ER)/histone demethylase KDM3A (JHDM2a) complex, which modifies KDM3A by tyrosine phosphorylation to regulate the transcriptional outcome at HOXA1 locus to promote the growth of tamoxifen-resistant breast cancer. It is also well established that ACK1 regulates the activity of androgen receptor (AR) by tyrosine phosphorylation to fuel the growth of hormone-refractory prostate cancers. Further, recent explosion in genomic sequencing has revealed recurrent ACK1 gene amplification and somatic mutations in a variety of human malignancies, providing a molecular basis for its role in neoplastic transformation. In this review, we will discuss the various facets of ACK1 signaling, including its newly uncovered epigenetic regulator function, which enables cells to bypass the blockade to major survival pathways to promote resistance to standard cancer treatments. Not surprisingly, cancer cells appear to acquire an 'addiction’ to ACK1-mediated survival, particularly under stress conditions, such as growth factor deprivation or genotoxic insults or hormone deprivation. With the accelerated development of potent and selective ACK1 inhibitors, targeted treatment for cancers harboring aberrant ACK1 activity may soon become a clinical reality." @default.
• W2013750047 created "2016-06-24" @default.
• W2013750047 creator A5082062478 @default.
• W2013750047 creator A5087068240 @default.
• W2013750047 date "2014-10-27" @default.
• W2013750047 modified "2023-10-06" @default.
• W2013750047 title "ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers" @default.
• W2013750047 cites W1511288644 @default.
• W2013750047 cites W1768092345 @default.
• W2013750047 cites W1964717481 @default.
• W2013750047 cites W1971560415 @default.
• W2013750047 cites W1972452124 @default.
• W2013750047 cites W1972759185 @default.
• W2013750047 cites W1976719421 @default.
• W2013750047 cites W1984621921 @default.
• W2013750047 cites W1985184433 @default.
• W2013750047 cites W1985225299 @default.
• W2013750047 cites W1985663823 @default.
• W2013750047 cites W1986276126 @default.
• W2013750047 cites W1994545036 @default.
• W2013750047 cites W2001604240 @default.
• W2013750047 cites W2001847316 @default.
• W2013750047 cites W2003955264 @default.
• W2013750047 cites W2004037338 @default.
• W2013750047 cites W2005658600 @default.
• W2013750047 cites W2014477103 @default.
• W2013750047 cites W2021128108 @default.
• W2013750047 cites W2029186861 @default.
• W2013750047 cites W2039377638 @default.
• W2013750047 cites W2042714596 @default.
• W2013750047 cites W2045555205 @default.
• W2013750047 cites W2047425894 @default.
• W2013750047 cites W2055013229 @default.
• W2013750047 cites W2059968629 @default.
• W2013750047 cites W2061152791 @default.
• W2013750047 cites W2062344593 @default.
• W2013750047 cites W2068319312 @default.
• W2013750047 cites W2075172927 @default.
• W2013750047 cites W2081511916 @default.
• W2013750047 cites W2086658271 @default.
• W2013750047 cites W2088442622 @default.
• W2013750047 cites W2088948163 @default.
• W2013750047 cites W2091322376 @default.
• W2013750047 cites W2097312459 @default.
• W2013750047 cites W2100773081 @default.
• W2013750047 cites W2106499057 @default.
• W2013750047 cites W2132448632 @default.
• W2013750047 cites W2141647078 @default.
• W2013750047 cites W2142900503 @default.
• W2013750047 cites W2143004704 @default.
• W2013750047 cites W2146751822 @default.
• W2013750047 cites W2147529404 @default.
• W2013750047 cites W2149055519 @default.
• W2013750047 cites W2154345947 @default.
• W2013750047 cites W2155046477 @default.
• W2013750047 cites W2166969772 @default.
• W2013750047 cites W2178583781 @default.
• W2013750047 cites W2331302298 @default.
• W2013750047 doi "https://doi.org/10.1038/onc.2014.350" @default.
• W2013750047 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4411206" @default.
• W2013750047 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25347744" @default.
• W2013750047 hasPublicationYear "2014" @default.
• W2013750047 type Work @default.
• W2013750047 sameAs 2013750047 @default.
• W2013750047 citedByCount "103" @default.
• W2013750047 countsByYear W20137500472015 @default.
• W2013750047 countsByYear W20137500472016 @default.
• W2013750047 countsByYear W20137500472017 @default.
• W2013750047 countsByYear W20137500472018 @default.
• W2013750047 countsByYear W20137500472019 @default.
• W2013750047 countsByYear W20137500472020 @default.
• W2013750047 countsByYear W20137500472021 @default.
• W2013750047 countsByYear W20137500472022 @default.
• W2013750047 countsByYear W20137500472023 @default.
• W2013750047 crossrefType "journal-article" @default.
• W2013750047 hasAuthorship W2013750047A5082062478 @default.
• W2013750047 hasAuthorship W2013750047A5087068240 @default.
• W2013750047 hasBestOaLocation W20137500471 @default.
• W2013750047 hasConcept C101544691 @default.
• W2013750047 hasConcept C157333092 @default.
• W2013750047 hasConcept C170493617 @default.
• W2013750047 hasConcept C180361614 @default.
• W2013750047 hasConcept C23440912 @default.
• W2013750047 hasConcept C2775960820 @default.
• W2013750047 hasConcept C42362537 @default.
• W2013750047 hasConcept C502942594 @default.
• W2013750047 hasConcept C54355233 @default.
• W2013750047 hasConcept C62478195 @default.
• W2013750047 hasConcept C86803240 @default.
• W2013750047 hasConcept C95444343 @default.
• W2013750047 hasConceptScore W2013750047C101544691 @default.
• W2013750047 hasConceptScore W2013750047C157333092 @default.
• W2013750047 hasConceptScore W2013750047C170493617 @default.
• W2013750047 hasConceptScore W2013750047C180361614 @default.
• W2013750047 hasConceptScore W2013750047C23440912 @default.
• W2013750047 hasConceptScore W2013750047C2775960820 @default.
• W2013750047 hasConceptScore W2013750047C42362537 @default.
• W2013750047 hasConceptScore W2013750047C502942594 @default.

• next